Derek Finnegan If you have spent any time looking into medical cannabis in the UK, you have likely encountered bold statistics splashed across websites and social media ads. One of the most prominent claims currently circulating is from Releaf, a digital-first clinic that states it has been “chosen by over 220,000 people.”
As a wellness coach, I hear this question from my clients constantly: “Is that even possible? Are there really that many people accessing this, or is this just marketing fluff?”
To answer that, we have to peel back the layers of the UK’s complex medical cannabis landscape. We need to look at the legislative history, the reality of the NHS, and why private clinics have become the primary gateway for thousands of patients. Let’s look at the numbers, the context, and what these claims actually mean for you as a patient.
The 2018 Legal Pivot: A Door Left Ajar
To understand the current “Releaf 220,000 claim,” we first have to rewind to November 2018. This was the moment the UK government rescheduled cannabis-based products for medicinal use (CBPMs). For many chronic pain, anxiety, and epilepsy patients, it felt like a monumental breakthrough. But in reality, it was a change in *classification*, not a change in *access*.
The 2018 law moved medical cannabis from Schedule 1 (no therapeutic value) to Schedule 2 (legally prescribable under strict conditions). It did not legalize general access, and it certainly did not provide a framework for a GP to hand out a prescription like they cuindependent.com would for an antibiotic. Instead, it placed the power strictly in the hands of specialist consultants—and only for specific, treatment-resistant conditions.
What the 2018 change did:
- Allowed specialist doctors to prescribe cannabis-based medicines.
- Opened a legal pathway for private clinics to operate.
- Reduced the legal risk for patients previously sourcing products through illicit channels.
What the 2018 change did NOT do:
- It did not mandate NHS coverage for all patients.
- It did not make it easier for the average patient to get a prescription through their local GP.
- It created a “postcode lottery” where access became dependent on whether you could afford private care.
NHS Caution: The Great Prescribing Bottleneck
When we discuss UK clinic popularity, we have to address the elephant in the room: the NHS. While the legal pathway exists, the NHS guidelines (led by NICE) are notoriously narrow. They generally restrict prescriptions to a handful of specific conditions, such as rare forms of pediatric epilepsy, spasticity in multiple sclerosis, or chemotherapy-induced nausea.
For the millions of Britons suffering from chronic pain, fibromyalgia, anxiety, or insomnia, the NHS route is often a dead end. The clinical caution is understandable—healthcare providers are wary of long-term data gaps—but it left a massive, underserved population searching for alternatives. This is exactly where private clinics stepped in to fill the void, creating the surge in patient adoption numbers we see today.
Is the 220,000 Claim Believable?
When a company like Releaf reports that 220,000 people have “chosen” them, the first instinct is to compare that to total active prescriptions. However, we must distinguish between “active, monthly patients” and “people who interacted with the platform.”
In the digital health sector, “choosing” a clinic often starts with an online eligibility assessment. These tools are the entry point for almost everyone. A user visits a site, answers a series of questions, and the system determines if they meet the basic criteria to talk to a doctor. If 220,000 people have used that specific tool, the claim is entirely plausible, even if only a fraction of those individuals ultimately moved forward to a consultation or a prescription.
Breaking down the metrics:
Is the number likely a measure of total *inquiries* rather than *active patients*? Almost certainly. But in the world of telehealth, that is how success is measured. They have built a digital-first funnel that is arguably the most efficient in the UK.
The Shift Toward Telehealth Infrastructure
Why are private clinics so popular now compared to five years ago? It comes down to “digital-first healthcare infrastructure.” Before, seeking specialist help meant physical appointments, months of waiting lists, and the stress of explaining your condition to skeptical staff. Now, the process is streamlined.
For a busy person—which I know most of you are—the ability to complete an online eligibility assessment from your sofa and upload your GP summary directly to a secure portal is a game changer. This infrastructure doesn’t just make things faster; it makes them more accessible for people who might be physically limited by their conditions.
Comparison: The Patient Journey
What This Means for You
If you are looking at the 220,000 figure and wondering if it validates the service, think of it this way: Popularity in the private medical cannabis sector is a measure of “accessibility,” not necessarily “clinical superiority.”
Many patients choose these clinics because they are the only ones providing a consistent, legal pathway for conditions that are being ignored elsewhere. The “220,000” number indicates that a massive segment of the British population is desperate for an alternative to conventional medication and is willing to engage with digital platforms to find it.
As a wellness coach, here is my advice:
Do not be dazzled by the big numbers. When choosing a clinic, look past the marketing claims and ask the following:
- Is the medical team registered? Ensure the clinicians are on the GMC specialist register.
- Is the security robust? Since you are dealing with sensitive medical history via secure medical record uploads, check that the company is GDPR-compliant and uses encrypted pathways.
- What is the ongoing care plan? A good clinic isn’t just about the first prescription; it’s about follow-up appointments and adjusting your treatment based on how you feel.
The Bottom Line
Is Releaf’s claim believable? If we interpret it as the total number of people who have engaged with their digital tools and expressed interest in a solution, then yes—it is a realistic reflection of the current demand for private healthcare in the UK. The “220,000” number isn’t just a vanity metric; it is a clear signal that the status quo of NHS-only prescribing is failing a significant portion of the population.
The rise of these clinics reflects a broader shift toward a digital-first approach in medicine. Patients are taking their health into their own hands, using technology to bypass traditional barriers. While you should always perform your own due diligence before starting any new treatment, the existence of these large patient numbers proves one thing: you are not alone in your search for relief.
If you have been feeling “stuck” with your current treatment plan, know that the tools to explore legal, medically-supervised alternatives are more accessible than they have ever been. Just remember to treat the “marketing” with a grain of salt and keep your focus on the clinical care you actually need.
Disclaimer: I am a wellness coach, not a doctor. This content is for informational purposes and does not constitute medical advice. Always speak with your GP or a qualified medical specialist before starting or changing any medical treatment.
